CJC‑1295
Price range: 39,00$ through 52,00$
Description
CJC-1295 (with DAC) is a synthetic analog of growth hormone-releasing hormone (GHRH) modified with a Drug Affinity Complex (DAC) for extended duration of action. It is studied for its ability to increase endogenous GH and IGF-1 secretion over a prolonged period, with applications in metabolic, endocrine, and regenerative research. Epigenetix Labs supplies CJC-1295 (with DAC) as a 2 mg, high-purity, research-grade peptide for laboratory research use only. Not for human or veterinary use.
10 Research-Based Reasons to Study
- Sustained GH/IGF-1 elevation
- Supports long-term research models
- Body composition and metabolic studies
- Regenerative medicine research
- Growth disorder studies
- Chronic administration studies
- Muscle and bone health
- Cardiovascular/metabolic health
- Albumin-binding supports PK modeling
- GH axis feedback sensitivity research
Additional information
Additional information
| Weight | 0,006 kg |
|---|---|
| Dimensions | 1,5 × 1,5 × 3,5 cm |
| Research Applications | Endocrine and pituitary studies |
| Key Research Findings | Results in a 2–10x increase in GH and 1.5–3x increase in IGF-1 for over 6–11 days (Teichman et al., 2006) |
| Scientific Background | The addition of DAC enables CJC-1295 to bind albumin, extending its plasma half-life to 6–8 days and maintaining elevated GH/IGF-1 levels. |
| Purity & Manufacturing Standards | Epigenetix Labs CJC-1295 (with DAC) is synthesized by SPPS, purified by HPLC, and validated by MS. Each batch is manufactured in ISO 9001:2015-certified facilities to ≥98% purity. |
| Legal Disclaimer | For laboratory research use only. Not for human or veterinary use. Not for therapeutic, diagnostic, or food purposes. Not evaluated by the FDA or regulatory authorities. |
Reviews
There are no reviews yet.